Greetings esteemed readers of nature.com. Your choice of browser may slightly limit your viewing experience due to minimal CSS support. For an optimal experience, we recommend using a modern browser or disabling compatibility mode in Internet Explorer. In the interim, we are presenting the site without styles and JavaScript to ensure continued support.
This collection is a staunch supporter of research aligned with Sustainable Development Goal 3 – Ensuring healthy lives and promoting well-being for all at every stage of life. The realm of cancer research has undergone a paradigm shift with the advent of single-cell and spatial omics methodologies, along with their associated experimental and analytical tools. Inspired by groundbreaking initiatives like the Human Cell Atlas and the Human Tumor Atlas Network, this compilation seeks to showcase how these advanced techniques are employed to comprehensively characterize tumor composition, heterogeneity, therapy response, and other biologically and clinically significant traits.
Advancements in Cancer Cell Atlases
In a bid to expand the current repertoire of cancer cell atlases, Nature Communications, Communications Biology, and Scientific Reports are soliciting contributions that leverage cutting-edge omics methodologies and algorithms. Of particular interest are studies that fuse multimodal data and push the boundaries of spatial and temporal resolution. This concerted effort aims to bridge the gap between empirical observations and computational innovations, thereby fostering precision medicine and enhancing therapeutic approaches in oncology.
Exploring Tumor Evolution and Heterogeneity
One of the fundamental challenges in cancer research pertains to unraveling tumor evolution and heterogeneity. A study delves into the longitudinal trajectory of meningioma evolution by conducting single nuclei sequencing on matched primary and recurrent meningiomas. The results unveil a spectrum of cellular compositions and hierarchies within these tumors.
Characterizing Pituitary Neuroendocrine Tumors
The invasiveness and aggressiveness of pituitary neuroendocrine tumors (PitNETs) pose a conundrum for researchers. By employing single-cell RNA sequencing and spatial transcriptomics, investigators shed light on the tumor microenvironment of PitNETs, elucidating potential therapeutic targets and unveiling the mechanisms underlying tumor progression.
Unveiling the Impact of PTPN6 on Tumor Immunity
A multi-omic analysis uncovers the role of PTPN6 in modulating tumor immunity across diverse cancer types. Leveraging cancer signatures, the scMalignantFinder tool accurately identifies malignant cells in single-cell and spatial transcriptomics data, offering insights into tumor biology and immune landscape alterations.
Identifying Cell Niches with Spatial Omics
Deciphering the intricate features, structure, and functions of cell niches within tissues remains a formidable task. Researchers introduce scNiche, a computational framework that discerns and characterizes cell niches from spatial omics data at single-cell resolution, thereby enhancing our understanding of tissue microenvironments.
Revealing Heterogeneity in Cancer Progression
The dynamics of single-cell DNA replication timing (scRT) in cancer progression present a complex landscape due to genomic diversity. MnM, a machine learning tool, is developed to unveil heterogeneity-resolved scRT profiles across various cancer samples, including tumors, cell lines, and patient-derived xenografts.
Unraveling Pancreatic Tumor Heterogeneity
Integrating antibody-guided cell typing with mass spectrometry-based proteomics proves challenging yet rewarding. The SCPro approach emerges as a versatile multimodal spatial proteomics technique for delineating tissue proteome heterogeneity within pancreatic tumors, offering a deeper understanding of tumor complexity.
Probing Immune Interactions in Prostate Cancer
The intricate interplay between club-like cells and immunosuppressive myeloid cells in the prostate cancer microenvironment during treatment remains largely unexplored. Single-cell and spatial transcriptomics analyses elucidate these interactions across multiple treatment stages in a cohort of 120 patients, hinting at the potential contribution of club-like cells to treatment resistance.
Uncovering Myeloid Cell Dynamics in Lung Cancer
Myeloid cell populations wield significant influence over lung cancer progression. Through the lens of scRNA-seq and spatial transcriptomics, researchers discern alterations in the phenotype of macrophages within the tumor microenvironment, unveiling novel insights into the immune landscape of non-small cell lung cancer.
Systematic Analysis of Tumor Ecosystems
The advent of single-cell sequencing has revolutionized our understanding of the tumor microenvironment. Through an integrative analysis of single-cell and spatial transcriptomics data from over a thousand tumors spanning thirty cancer types, researchers identify interferon-enriched community states that serve as predictive markers of immunotherapeutic responses, paving the way for personalized cancer treatments.
In conclusion, the synergistic integration of single-cell and spatial omics methodologies has propelled cancer research into a new era of precision and depth. By unraveling the intricacies of tumor evolution, immune interactions, and therapeutic responses at unprecedented resolutions, these studies lay the foundation for tailored therapeutic interventions and enhanced patient outcomes in oncology.
Key Takeaways:
- Single-cell and spatial omics techniques offer unparalleled insights into tumor heterogeneity and evolution.
- Computational frameworks like scNiche and MnM enable in-depth analyses of tissue microenvironments and cancer progression dynamics.
- The integration of multimodal data using tools like SCPro enhances our understanding of tumor complexity and proteome heterogeneity.
- Unveiling immune interactions and cellular dynamics within cancer ecosystems provides crucial information for developing personalized therapeutic strategies.
Tags: transcriptomics
Read more on nature.com